PATHLIGHT Trademark

Trademark Overview


On Monday, November 18, 2024, a trademark application was filed for PATHLIGHT with the United States Patent and Trademark Office. The USPTO has given the PATHLIGHT trademark a serial number of 98859533. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 17, 2025. This trademark is owned by SAGA Diagnostics AB. The PATHLIGHT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Analytical medical research laboratory services; blood analysis services for scientific research purposes; consultancy in the field of scientific research; contract research services relating to molecular sciences; design and development of medical technology being diagnostic tests and cancer monitoring tests; laboratory services namely DNA testing services to determine paternity; genetic scientific research; research laboratory analysis services in the field of bacteriology; laboratory research in the field of gene expression; medical research laboratories; laboratory services for analytical testing of biological material such as DNA and RNA; laboratory testing of materials in the field of genetics and genetic engineering; provision of information relating to scientific research; research and development in the field of biotechnology; research laboratory analysis services in the pharmaceutical and biotechnology fields; scientific laboratory services; scientific research; scientific re...

Diagnostic preparations and materials being diagnostic agents and substances for medical purposes; biochemical preparations for the treatment of cancer; biological preparations for the treatment of cancer; chemical preparations for the treatment of cancer; chemical preparations for veterinary purposes, specifically for the treatment of cancer; nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; reagents for medical use

Human healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services in the field of oncology testing and detection and treatment of molecular residual disease; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; health care services offered through a network of health care providers on a contract basis in the field of oncology testing and detection and treatment of molecular residual disease; cancer screening services; laboratory analysis services relating to the treatment of persons provided by medical laboratories; medical and healthcare clinics in the field of oncology testing and detection and treatment of molecular residual disease; medical and healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services, namely monitoring of patients; pathology services, namely, analysis services, diagnostic services and monitoring...
pathlight

General Information


Serial Number98859533
Word MarkPATHLIGHT
Filing DateMonday, November 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, November 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2025

Trademark Statements


Goods and ServicesAnalytical medical research laboratory services; blood analysis services for scientific research purposes; consultancy in the field of scientific research; contract research services relating to molecular sciences; design and development of medical technology being diagnostic tests and cancer monitoring tests; laboratory services namely DNA testing services to determine paternity; genetic scientific research; research laboratory analysis services in the field of bacteriology; laboratory research in the field of gene expression; medical research laboratories; laboratory services for analytical testing of biological material such as DNA and RNA; laboratory testing of materials in the field of genetics and genetic engineering; provision of information relating to scientific research; research and development in the field of biotechnology; research laboratory analysis services in the pharmaceutical and biotechnology fields; scientific laboratory services; scientific research; scientific research and analysis in the field of genetics and genetic engineering; scientific research for medical purposes; scientific research conducted using databases; scientific services, namely scientific laboratory services; scientific testing services in the field of genetics and genetic engineering; medical and pharmacological research services
Goods and ServicesDiagnostic preparations and materials being diagnostic agents and substances for medical purposes; biochemical preparations for the treatment of cancer; biological preparations for the treatment of cancer; chemical preparations for the treatment of cancer; chemical preparations for veterinary purposes, specifically for the treatment of cancer; nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; reagents for medical use
Goods and ServicesHuman healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services in the field of oncology testing and detection and treatment of molecular residual disease; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; health care services offered through a network of health care providers on a contract basis in the field of oncology testing and detection and treatment of molecular residual disease; cancer screening services; laboratory analysis services relating to the treatment of persons provided by medical laboratories; medical and healthcare clinics in the field of oncology testing and detection and treatment of molecular residual disease; medical and healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services, namely monitoring of patients; pathology services, namely, analysis services, diagnostic services and monitoring services for studying diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 18, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 18, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAGA Diagnostics AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLund SE-22381
SE

Trademark Events


Event DateEvent Description
Monday, November 18, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 13, 2025ASSIGNED TO EXAMINER
Wednesday, May 21, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 21, 2025NON-FINAL ACTION E-MAILED
Wednesday, May 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 21, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, August 21, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, November 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER